Word Limit: This abstract category has a 300 word limit.
Abstract Deadline: Monday March 24, 2025, 11:59 PM Central Time.
Abstracts must describe a systematic review adhering to the guidelines and definitions established by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA for Abstracts statement) and include the 12-items published in the PRISMA for Abstracts checklist (http://www.prisma-statement.org/Extensions/Abstracts).
Abstracts must be structured with the PRISMA for Abstracts format: Background, methods, results, discussion, and other.
Abstracts will be evaluated based on merits of the 12 PRISMA for Abstracts checklist items: Title, objectives, eligibility criteria, information sources, risk of bias, included studies, synthesis of results, description of the effect, strengths and limitations of evidence, interpretation, funding, and registration.
Abstracts presented elsewhere, but important to clinical pharmacy, are encouraged as "Encore" submissions (see Encore Presentation details below).